Inovio Pharmaceuticals (INO +0.2%) announces that Thermo Fisher Scientific (TMO -0.8%) has signed a letter of intent to produce its COVID-19 vaccine candidate INO-4800.
TMO is the latest addition to a consortium of third-party manufacturers that INO is counting on to make 100M doses next year, if approved.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.